Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:20:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:50:02.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a visible 403 label and a Home button, indicating that access to the page is blocked. This reflects an access-control state change rather than updates to the page's substantive content.
    Difference
    0.5%
    Check dated 2026-09-27T20:00:28.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, preventing access to the study record and related documents. The visible page chrome remains, but the main study content is inaccessible.
    Difference
    16%
    Check dated 2026-09-20T19:46:47.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The site revision was updated to v3.6.6, representing a newer version of the ClinicalTrials.gov interface. This change likely includes minor fixes or improvements and does not alter the study content displayed on the page.
    Difference
    0.0%
    Check dated 2026-08-30T15:46:18.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5 on the page's history, indicating a minor maintenance update to the page documentation. The change does not alter study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T23:53:50.000Z thumbnail image

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.